Edwards Lifesciences EW Other current assets
Other current assets at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's other current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's other current assets?
- Edwards Lifesciences (EW) reported other current assets of $329.5M in Q1 2026.
- How has Edwards Lifesciences's other current assets changed year-over-year?
- Edwards Lifesciences's other current assets increased by 8.2% year-over-year, from $304.5M to $329.5M.
- What is the long-term trend for Edwards Lifesciences's other current assets?
- Over 5 years (2020 to 2025), Edwards Lifesciences's other current assets has grown at a 10.3% compound annual growth rate (CAGR), from $208.2M to $339.3M.
- What does other current assets mean?
- This is a catch-all category for current assets that do not fit into specific classifications like cash, receivables, or inventory. It may include short-term derivative assets, deferred tax assets, or other miscellaneous items expected to be realized within one year. It provides a view of the remaining liquid resources available to the firm.